651 related articles for article (PubMed ID: 7642022)
21. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
[TBL] [Abstract][Full Text] [Related]
22. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
23. [Stratification of the thromboembolic risk in patients with non-rheumatic atrial fibrillation: assessment of left atrial dysfunction].
Scardi S; Pandullo C; Mazzone C; Goldstein D; Zecchin M
G Ital Cardiol; 1996 Mar; 26(3):273-85. PubMed ID: 8690183
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
Pengo V; De Caterina R
Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective study.
Da Costa A; Romeyer C; Mourot S; Messier M; Cerisier A; Faure E; Isaaz K
Eur Heart J; 2002 Mar; 23(6):498-506. PubMed ID: 11863353
[TBL] [Abstract][Full Text] [Related]
26. Atrial fibrillation and embolic complications.
Maru M
East Afr Med J; 1997 Jan; 74(1):3-5. PubMed ID: 9145567
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
[TBL] [Abstract][Full Text] [Related]
28. [Embolic complications of chronic atrial fibrillation].
Koenig A; Théolade R; Chauvin M; Brechenmacher C
Arch Mal Coeur Vaiss; 1992 Mar; 85(3):315-23. PubMed ID: 1575609
[TBL] [Abstract][Full Text] [Related]
29. [Survey of atrial fibrillation and thromboembolism in the elderly: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
J Cardiol; 1999 Jan; 33(1):27-35. PubMed ID: 10028459
[TBL] [Abstract][Full Text] [Related]
30. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
[TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Pengo V; Legnani C; Noventa F; Palareti G;
Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
[TBL] [Abstract][Full Text] [Related]
32. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
Disertori M; Lombardi F; Barlera S; Maggioni AP; Favero C; Franzosi MG; Lucci D; Staszewsky L; Fabbri G; Quintarelli S; Bianconi L; Latini R
Am Heart J; 2011 Aug; 162(2):382-9. PubMed ID: 21835301
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
35. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
Halperin JL;
Am Heart J; 2003 Sep; 146(3):431-8. PubMed ID: 12947359
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
37. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
[TBL] [Abstract][Full Text] [Related]
39. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon.
Ntep-Gweth M; Zimmermann M; Meiltz A; Kingue S; Ndobo P; Urban P; Bloch A
Europace; 2010 Apr; 12(4):482-7. PubMed ID: 20179174
[TBL] [Abstract][Full Text] [Related]
40. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
